Natera, Inc. (NASDAQ:NTRA) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks,
Agenus (AGEN) Q3 2024 Earnings Call Transcript
Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only mode, until the question-and-answer session. Please note this event is being recorded. If anyone has any objections, you may disconnect at this time.
Sonos (SONO) Q4 2024 Earnings Call Transcript
Operator Thank you for standing by, and welcome to the Sonos fourth quarter 2024 conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.
Cava Group (CAVA) Q3 2024 Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the CAVA third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded on Tuesday, November 12th, 2024. I would now like to turn the conference over to Matt Milanovich.
Nu Holdings Ltd. (NU) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Conference Call November 13, 2024 5:00 PM ETCompany ParticipantsJorg Friedemann - IR OfficerDavid Vélez
Westport Fuel Systems (WPRT) Q3 2024 Earnings Call Transcript
Welcome to Westport Fuel Systems' third quarter conference call for 2024. This call is being held to coincide with the press release containing Westport's financial results that was issued yesterday.
StoneCo (STNE) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Nov 12, 2024, 5:00 p.m. ET Good evening, everyone. Thank you for standing by. Welcome to StoneCo's third quarter 2024 earnings conference call. By now, everyone should have access to our earnings release.
scPharmaceuticals Inc. (SCPH) Q3 2024 Earnings Call Transcript
Good afternoon, and welcome to scPharmaceuticals' Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a question-and-answer session.
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript
Welcome, ladies and gentlemen, to the third quarter of fiscal year 2024 earnings conference call for Organogenesis Holdings, Inc. At this time, all participants have been placed in listen-only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly.
Insider Monkey on MSN20h
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call Transcript
They also highlighted the recently initiated Phase 1/2 trial of GEN-1057 in malignant solid tumors. At the ESMO conference, ...
Merus: Petosemtamab Set Up For December 2024 Data Presentation
Merus’ zenocutuzumab is nearing FDA approval, and petosemtamab shows promise. Learn why MRUS stock could rise as the company ...
Morningstar27d
TME Pharma Reports H1 2024 Financial Results and Provides Business and Clinical Update
at the European Society for Medical Oncology (ESMO) conference in September 2024. The ESMO presentation further revealed statistically significant improvement in survival for this triple ...
Business Insider13h
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
“During the third quarter and at the recent SITC conference, we presented data from our Phase 1a ... Provide updated RFS and OS data in an oral presentation at the 2024 ESMO Immuno-Oncology ...
Seeking Alpha7d
Personalis, Inc. (PSNL) Q3 2024 Earnings Call Transcript
Two of our key studies were highlighted during the 2024 ESMO Conference in Spain. First, an update on our work with the TRACERx consortium in the area of lung cancer was presented by Charlie Swanton ...
Q3 2024 BioNTech SE Earnings Call
Welcome to BioNTech's third quarter 2024 earnings call. I would like to hand the call over to Michael Horowicz Director, Investor Relations. Please go ahead.
Sutro Biopharma Reports Third Quarter 2024 Financial Results and Business Highlights
Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology -- Two new ...
AZoM on MSN2d
esmo group launches Apollo Quad Handler
esmo group has launched its latest product—the Apollo Quad Handler. Designed to bridge the gap between the engineering and ...
Yahoo Finance1d
Q3 2024 Agenus Inc Earnings Call
I would now like to turn the conference over to Alexa buffet from corporate communications ... The initial data we presented at ESMO GI in 2024 just a few months ago from the Cornell study ...